Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: fillet (3), clean (268), prepare (1000)

Epcoritamab -Cycle 1 (Priming)

Description: Chemotherapy Protocol LYMPHOMA EPCORITAMAB -Cycle 1 - (28 Day -Priming) Regimen • Lymphoma-Epcoritamab – Cycle 1- (28 day -Priming) Indication •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-1-Priming-Ver1.pdf

AmB-Axicabtagene ciloleucel-Cyclophosphamide (500)-Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY Large B-cell Lymphoma (LBL) AmB- AXICEL – CYCLOPHOSPHAMIDE (500) –
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Axicabtagene-ciloleucel-Cyclophosphamide-500-Fludarabine-30.pdf

Inflammatory bowel disease service - patient information

Description: If you have ulcerative colitis, Crohn's disease or another IBD, you will be cared for by our IBD service team.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Inflammatory-bowel-disease-service-1647-PIL.pdf

Going home on parenteral support (adults) - patient information

Description: This factsheet contains useful information about adults going home from hospital on parenteral support (fluid or nutrition given through a central
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Going-home-on-parenteral-support-adults-2946-PIL.pdf

Diabetes: managing your foot wound - patient information

Description: You have been given this factsheet to help you recover from your foot ulcer or recent foot surgery. Please keep it
Url: /Media/UHS-website-2019/Patientinformation/Diabetes/Diabetes-managing-your-foot-wound-1473-PIL.pdf

Lutetium-177 prostate specific membrane antigen (PSMA) therapy - patient information

Description: This factsheet explains what Lutetium-177 prostate specific membrane antigen (PSMA) therapy is, what the therapy involves, and what the possible
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Lutetium-177-prostate-specific-membrane-antigen-PSMA-therapy-2881-PIL.pdf

Rifampicin and clindamycin for hidradenitis suppurativa in adults - patient information

Description: This factsheet explains what rifampicin and clindamycin are, how to take the medicines and the possible side effects.
Url: /Media/UHS-website-2019/Patientinformation/Skin/Rifampicin-and-clindamycin-for-hidradenitis-suppurativa-in-adults-3649-PIL.pdf

Risk-reducing bilateral salpingo-oophorectomy - patient information

Description: This booklet explains what a risk-reducing bilateral salpingo-oophorectomy is and what the operation involves to help you decide whether
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Risk-reducing-bilateral-salpingo-oophorectomy-1434-PIL.pdf

Talimogene laherparepvec (T-VEC)

Description: Chemotherapy Protocol SKIN CANCER Talimogene laherparepvec (T-VEC) Regimen • Skin – Talimogene laherparepvec (T-VEC) Indication • Talimogene
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Talimogene-laherparepvec-T-VEC.pdf

AmB - Brexucel - Cyclophosphamide (500) - Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY Mantle Cell lymphoma (MCL) AmB – BREXUCEL – CYCLOPHOSPHAMIDE (500)
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Brexucel-Cyclophosphamide-500-Fludarabine-30-Ver-1.pdf

241 to 250 of 363

Previous … 23 24 25 26 27 … Next